Royal Society of Chemistry, Biomaterials Science, 19(10), p. 5596-5607, 2022
DOI: 10.1039/d2bm00988a
Full text: Unavailable
The combination strategy of MET/MMH NPs/αOX40 provides a novel and effective clinical option for colorectal cancer therapy.